Prognosis of primary aldosteronism in japan: Results from a nationwide epidemiological study

Yoshihiro Miyake, Keiko Tanaka, Tetsuo Nishikawa, Mitsuhide Naruse, Ryoichi Takayanagi, Hironobu Sasano, Yoshiyu Takeda, Hirotaka Shibata, Masakatsu Sone, Fumitoshi Satoh, Masanobu Yamada, Hajime Ueshiba, Takuyuki Katabami, Yasumasa Iwasaki, Hirotoshi Tanaka, Yusuke Tanahashi, Shigeru Suzuki, Tomonobu Hasegawa, Noriyuki Katsumata, Toshihiro TajimaToshihiko Yanase

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The Research Committee of Disorders of Adrenal Hormones, Japan, undertook a nationwide epidemiological study of primary aldosteronism (PA). The present study was undertaken as a part of this study to reveal the relationship between type of treatment and the prognosis of PA. In the primary survey, 4161 patients with PA during the period January 1, 2003-December 31, 2007 were reported from 3252 departments of internal medicine, pediatrics and urology. In the secondary survey, a questionnaire that requested detailed clinical information on individual patients was sent to those departments reporting patients in the primary survey. In total, data on 1706 patients with PA were available in the present study. Among patients with bilateral or unilateral aldosterone-producing adenoma, after adjustment for age at which prognosis was examined, sex, surgical treatment and medical treatment, surgical treatment was significantly associated with amelioration of hypertension (adjusted odds ratio [OR]: 0.47 [95% confidence interval (CI): 0.29-0.77]) and hypokalemia (adjusted OR: 0.17 [95% CI: 0.11-0.29]). No significant relationship was observed between medical treatment and such prognosis in this group of patients. Among patients with bilateral or unilateral adrenal hyperplasia, surgical, but not medical, treatment was significantly associated with amelioration of hypokalemia (adjusted OR: 0.23 [95% CI: 0.06-0.74]), while there was no relationship between surgical or medical treatment and the prognosis of hypertension. In conclusion, surgery offered a better prognosis of PA than medication with regards to hypertension and hypokalemia, with the limitation that a new anti-aldosterone drug, eplerenone, was not available during the study period.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalEndocrine Journal
Volume61
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Hyperaldosteronism
Epidemiologic Studies
Japan
Hypokalemia
Odds Ratio
Confidence Intervals
Hypertension
Aldosterone
Therapeutics
Urology
Internal Medicine
Adenoma
Hyperplasia
Hormones
Pediatrics
Surveys and Questionnaires
Research
Pharmaceutical Preparations

Keywords

  • Medical treatment
  • Nationwide epidemiological study
  • Primary aldosteronism
  • Prognosis
  • Surgical treatment

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Miyake, Y., Tanaka, K., Nishikawa, T., Naruse, M., Takayanagi, R., Sasano, H., ... Yanase, T. (2014). Prognosis of primary aldosteronism in japan: Results from a nationwide epidemiological study. Endocrine Journal, 61(1), 35-40. https://doi.org/10.1507/endocrj.EJ13-0353

Prognosis of primary aldosteronism in japan : Results from a nationwide epidemiological study. / Miyake, Yoshihiro; Tanaka, Keiko; Nishikawa, Tetsuo; Naruse, Mitsuhide; Takayanagi, Ryoichi; Sasano, Hironobu; Takeda, Yoshiyu; Shibata, Hirotaka; Sone, Masakatsu; Satoh, Fumitoshi; Yamada, Masanobu; Ueshiba, Hajime; Katabami, Takuyuki; Iwasaki, Yasumasa; Tanaka, Hirotoshi; Tanahashi, Yusuke; Suzuki, Shigeru; Hasegawa, Tomonobu; Katsumata, Noriyuki; Tajima, Toshihiro; Yanase, Toshihiko.

In: Endocrine Journal, Vol. 61, No. 1, 2014, p. 35-40.

Research output: Contribution to journalArticle

Miyake, Y, Tanaka, K, Nishikawa, T, Naruse, M, Takayanagi, R, Sasano, H, Takeda, Y, Shibata, H, Sone, M, Satoh, F, Yamada, M, Ueshiba, H, Katabami, T, Iwasaki, Y, Tanaka, H, Tanahashi, Y, Suzuki, S, Hasegawa, T, Katsumata, N, Tajima, T & Yanase, T 2014, 'Prognosis of primary aldosteronism in japan: Results from a nationwide epidemiological study', Endocrine Journal, vol. 61, no. 1, pp. 35-40. https://doi.org/10.1507/endocrj.EJ13-0353
Miyake, Yoshihiro ; Tanaka, Keiko ; Nishikawa, Tetsuo ; Naruse, Mitsuhide ; Takayanagi, Ryoichi ; Sasano, Hironobu ; Takeda, Yoshiyu ; Shibata, Hirotaka ; Sone, Masakatsu ; Satoh, Fumitoshi ; Yamada, Masanobu ; Ueshiba, Hajime ; Katabami, Takuyuki ; Iwasaki, Yasumasa ; Tanaka, Hirotoshi ; Tanahashi, Yusuke ; Suzuki, Shigeru ; Hasegawa, Tomonobu ; Katsumata, Noriyuki ; Tajima, Toshihiro ; Yanase, Toshihiko. / Prognosis of primary aldosteronism in japan : Results from a nationwide epidemiological study. In: Endocrine Journal. 2014 ; Vol. 61, No. 1. pp. 35-40.
@article{b9d30c1e65824b08a0276839af19dd36,
title = "Prognosis of primary aldosteronism in japan: Results from a nationwide epidemiological study",
abstract = "The Research Committee of Disorders of Adrenal Hormones, Japan, undertook a nationwide epidemiological study of primary aldosteronism (PA). The present study was undertaken as a part of this study to reveal the relationship between type of treatment and the prognosis of PA. In the primary survey, 4161 patients with PA during the period January 1, 2003-December 31, 2007 were reported from 3252 departments of internal medicine, pediatrics and urology. In the secondary survey, a questionnaire that requested detailed clinical information on individual patients was sent to those departments reporting patients in the primary survey. In total, data on 1706 patients with PA were available in the present study. Among patients with bilateral or unilateral aldosterone-producing adenoma, after adjustment for age at which prognosis was examined, sex, surgical treatment and medical treatment, surgical treatment was significantly associated with amelioration of hypertension (adjusted odds ratio [OR]: 0.47 [95{\%} confidence interval (CI): 0.29-0.77]) and hypokalemia (adjusted OR: 0.17 [95{\%} CI: 0.11-0.29]). No significant relationship was observed between medical treatment and such prognosis in this group of patients. Among patients with bilateral or unilateral adrenal hyperplasia, surgical, but not medical, treatment was significantly associated with amelioration of hypokalemia (adjusted OR: 0.23 [95{\%} CI: 0.06-0.74]), while there was no relationship between surgical or medical treatment and the prognosis of hypertension. In conclusion, surgery offered a better prognosis of PA than medication with regards to hypertension and hypokalemia, with the limitation that a new anti-aldosterone drug, eplerenone, was not available during the study period.",
keywords = "Medical treatment, Nationwide epidemiological study, Primary aldosteronism, Prognosis, Surgical treatment",
author = "Yoshihiro Miyake and Keiko Tanaka and Tetsuo Nishikawa and Mitsuhide Naruse and Ryoichi Takayanagi and Hironobu Sasano and Yoshiyu Takeda and Hirotaka Shibata and Masakatsu Sone and Fumitoshi Satoh and Masanobu Yamada and Hajime Ueshiba and Takuyuki Katabami and Yasumasa Iwasaki and Hirotoshi Tanaka and Yusuke Tanahashi and Shigeru Suzuki and Tomonobu Hasegawa and Noriyuki Katsumata and Toshihiro Tajima and Toshihiko Yanase",
year = "2014",
doi = "10.1507/endocrj.EJ13-0353",
language = "English",
volume = "61",
pages = "35--40",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Prognosis of primary aldosteronism in japan

T2 - Results from a nationwide epidemiological study

AU - Miyake, Yoshihiro

AU - Tanaka, Keiko

AU - Nishikawa, Tetsuo

AU - Naruse, Mitsuhide

AU - Takayanagi, Ryoichi

AU - Sasano, Hironobu

AU - Takeda, Yoshiyu

AU - Shibata, Hirotaka

AU - Sone, Masakatsu

AU - Satoh, Fumitoshi

AU - Yamada, Masanobu

AU - Ueshiba, Hajime

AU - Katabami, Takuyuki

AU - Iwasaki, Yasumasa

AU - Tanaka, Hirotoshi

AU - Tanahashi, Yusuke

AU - Suzuki, Shigeru

AU - Hasegawa, Tomonobu

AU - Katsumata, Noriyuki

AU - Tajima, Toshihiro

AU - Yanase, Toshihiko

PY - 2014

Y1 - 2014

N2 - The Research Committee of Disorders of Adrenal Hormones, Japan, undertook a nationwide epidemiological study of primary aldosteronism (PA). The present study was undertaken as a part of this study to reveal the relationship between type of treatment and the prognosis of PA. In the primary survey, 4161 patients with PA during the period January 1, 2003-December 31, 2007 were reported from 3252 departments of internal medicine, pediatrics and urology. In the secondary survey, a questionnaire that requested detailed clinical information on individual patients was sent to those departments reporting patients in the primary survey. In total, data on 1706 patients with PA were available in the present study. Among patients with bilateral or unilateral aldosterone-producing adenoma, after adjustment for age at which prognosis was examined, sex, surgical treatment and medical treatment, surgical treatment was significantly associated with amelioration of hypertension (adjusted odds ratio [OR]: 0.47 [95% confidence interval (CI): 0.29-0.77]) and hypokalemia (adjusted OR: 0.17 [95% CI: 0.11-0.29]). No significant relationship was observed between medical treatment and such prognosis in this group of patients. Among patients with bilateral or unilateral adrenal hyperplasia, surgical, but not medical, treatment was significantly associated with amelioration of hypokalemia (adjusted OR: 0.23 [95% CI: 0.06-0.74]), while there was no relationship between surgical or medical treatment and the prognosis of hypertension. In conclusion, surgery offered a better prognosis of PA than medication with regards to hypertension and hypokalemia, with the limitation that a new anti-aldosterone drug, eplerenone, was not available during the study period.

AB - The Research Committee of Disorders of Adrenal Hormones, Japan, undertook a nationwide epidemiological study of primary aldosteronism (PA). The present study was undertaken as a part of this study to reveal the relationship between type of treatment and the prognosis of PA. In the primary survey, 4161 patients with PA during the period January 1, 2003-December 31, 2007 were reported from 3252 departments of internal medicine, pediatrics and urology. In the secondary survey, a questionnaire that requested detailed clinical information on individual patients was sent to those departments reporting patients in the primary survey. In total, data on 1706 patients with PA were available in the present study. Among patients with bilateral or unilateral aldosterone-producing adenoma, after adjustment for age at which prognosis was examined, sex, surgical treatment and medical treatment, surgical treatment was significantly associated with amelioration of hypertension (adjusted odds ratio [OR]: 0.47 [95% confidence interval (CI): 0.29-0.77]) and hypokalemia (adjusted OR: 0.17 [95% CI: 0.11-0.29]). No significant relationship was observed between medical treatment and such prognosis in this group of patients. Among patients with bilateral or unilateral adrenal hyperplasia, surgical, but not medical, treatment was significantly associated with amelioration of hypokalemia (adjusted OR: 0.23 [95% CI: 0.06-0.74]), while there was no relationship between surgical or medical treatment and the prognosis of hypertension. In conclusion, surgery offered a better prognosis of PA than medication with regards to hypertension and hypokalemia, with the limitation that a new anti-aldosterone drug, eplerenone, was not available during the study period.

KW - Medical treatment

KW - Nationwide epidemiological study

KW - Primary aldosteronism

KW - Prognosis

KW - Surgical treatment

UR - http://www.scopus.com/inward/record.url?scp=84893422145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893422145&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ13-0353

DO - 10.1507/endocrj.EJ13-0353

M3 - Article

C2 - 24077222

AN - SCOPUS:84893422145

VL - 61

SP - 35

EP - 40

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 1

ER -